Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glanzmann's Thrombasthenia”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Not applicableLooking for participantsNCT04119908
What this trial is testing

Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases

Who this might be right for
Von Willebrand DiseasesGlanzmann Thrombasthenia
University Hospital, Lille 400
Not applicableStudy completedNCT03372993
What this trial is testing

Prospective, Non-interventional Study to Evaluate Immunogenicity of AryoSeven

Who this might be right for
Hemophilia A With InhibitorHemophilia B With InhibitorFactor VII Deficiency+1 more
AryoGen Pharmed Co. 200
Early research (Phase 1)Study completedNCT01561417
What this trial is testing

Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male Subjects

Who this might be right for
Acquired Bleeding DisorderAcquired HaemophiliaCongenital Bleeding Disorder+5 more
Novo Nordisk A/S 28
Not applicableEnded earlyNCT02179359
What this trial is testing

Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies

Who this might be right for
Sickle Cell DiseaseTransfusion Dependent Alpha- or Beta- ThalassemiaDiamond Blackfan Anemia+5 more
Masonic Cancer Center, University of Minnesota 38
Testing effectiveness (Phase 2)Ended earlyNCT04548791
What this trial is testing

Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding Disorders

Who this might be right for
Factor VII DeficiencyGlanzmann ThrombastheniaHemophilia A With Inhibitor
Catalyst Biosciences 19
Not applicableLooking for participantsNCT06820515
What this trial is testing

ATHNdataset Registry

Who this might be right for
HemophiliaThrombosisHemophilia A+6 more
American Thrombosis and Hemostasis Network 200,000
Not applicableLooking for participantsNCT00230165
What this trial is testing

The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders.

Who this might be right for
Glanzmann Thrombasthenia
Rockefeller University 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT06211634
What this trial is testing

Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia

Who this might be right for
Glanzmann Thrombasthenia
Hemab ApS 57
Testing effectiveness (Phase 2)Ended earlyNCT03333486
What this trial is testing

Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Leukemia in RemissionAcute Lymphoblastic Leukemia+34 more
Roswell Park Cancer Institute 31
Not applicableNot Yet RecruitingNCT06204042
What this trial is testing

Multinational Glanzmann Study

Who this might be right for
Glanzmann Thrombasthenia
UMC Utrecht 200
Early research (Phase 1)Study completedNCT01917708
What this trial is testing

Bone Marrow Transplant With Abatacept for Non-Malignant Diseases

Who this might be right for
Hurler SyndromeFanconi AnemiaGlanzmann Thrombasthenia+12 more
Emory University 10
Not applicableStudy completedNCT01876745
What this trial is testing

Evaluate Safety and Efficacy of NovoSeven® in Patients With Glanzmann's Thrombasthenia in Japan

Who this might be right for
Congenital Bleeding DisorderGlanzmann's Disease
Novo Nordisk A/S 4
Not applicableStudy completedNCT04595617
What this trial is testing

Anti-αIIbβ3 Immunization in Glanzmann Thrombasthenia: Prevalence and Associated Risk Factors: Thrombasthenia Anti-αIIbβ3 Antibodies Study (TAAS)

Who this might be right for
Glanzmann Thrombasthenia
University Hospital, Bordeaux 28
Testing effectiveness (Phase 2)Looking for participantsNCT07136857
What this trial is testing

Eptacog Beta in Glanzmann's (HeT_LFB-Strength-Study_FID531)

Who this might be right for
Glanzmann Thrombasthenia
Emory University 6
Not applicableStudy completedNCT00697320
What this trial is testing

Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany

Who this might be right for
Congenital Bleeding DisorderCongenital FVII DeficiencyGlanzmann's Disease+2 more
Novo Nordisk A/S 64
Not applicableStudy completedNCT05315232
What this trial is testing

The Experiences of People Who Live With Glanzmanns Thrombasthenia.

Who this might be right for
Glanzmann Thrombasthenia
Haemnet 122
Not applicableEnded earlyNCT01319851
What this trial is testing

Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
ThalassemiaSickle Cell DiseaseGlanzmann Thrombasthenia+10 more
Emory University 3
Not applicableStudy completedNCT01476423
What this trial is testing

Observational Registry of the Treatment of Glanzmann's Thrombasthenia

Who this might be right for
Congenital Bleeding DisorderGlanzmann's Disease
Novo Nordisk A/S 218
Not applicableStudy completedNCT06234813
What this trial is testing

Targeting TFPI With Concizumab to Improve Haemostasis in Glanzmann Thrombasthenia Patients: an in Vitro Study

Who this might be right for
Glanzmann Thrombasthenia
University Hospital, Bordeaux 20